Relapsed or Refractory B-cell Hematologic Malignancies
·MeSH: Recurrence
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 1(1)
Frequently asked questions
How many drugs are in development for Relapsed or Refractory B-cell Hematologic Malignancies?
BioSniper tracks 1 drug in development for Relapsed or Refractory B-cell Hematologic Malignancies across 1 company.
How many clinical trials target Relapsed or Refractory B-cell Hematologic Malignancies?
There are 1 clinical trial targeting Relapsed or Refractory B-cell Hematologic Malignancies tracked by BioSniper.
Analyze SUNSHINE BIOPHARMA INC.'s Relapsed or Refractory B-cell Hematologic Malignancies pipeline with AI
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start AI Analysis